HTGF is a German public-private early-stage investor founded in 2005 and headquartered in Bonn, with additional offices in Berlin and Munich. It is one of Europe’s most active seed investors and focuses on pre-seed and seed-stage technology companies across multiple high-tech sectors. Its model is built around being a first institutional backer for science and technology startups emerging from the German ecosystem.

Within life sciences and medtech, HTGF supports companies in biotech, diagnostics, and medical technology, often those spinning out from universities and research institutes. Its strength lies in early conviction, broad network access, and experience helping technical founders navigate the first stages of company formation and follow-on financing. It is not neurotech-exclusive, but it is highly relevant to companies with strong research origins.

HTGF focuses primarily on Germany, while also maintaining broader European reach. For neurotech, it is particularly relevant to very early-stage medtech, diagnostics, and deep-tech neuro startups emerging from German research institutions. It is one of the most important first-check investors for the German neurotechnology pipeline.